Hormonal therapy in cancer of the breast 16. The effect of Delta 1-testololactone on clinical course and hormonal excretion

Cancer. 1960 Sep-Oct:13:1017-20. doi: 10.1002/1097-0142(196009/10)13:5<1017::aid-cncr2820130523>3.0.co;2-1.
No abstract available

MeSH terms

  • Breast Neoplasms / therapy*
  • Breast*
  • Humans
  • Progesterone / analogs & derivatives
  • Testolactone*

Substances

  • testololactone
  • Progesterone
  • Testolactone